Switch to:
More From Other Websites
Lilly must divest Sentinel products after FTC nod on Novartis deal Dec 22 2014
Lilly must divest Sentinel products after FTC nod on Novartis deal Dec 22 2014
Missed the Juno IPO? Take a Look at MabVax Dec 22 2014
United Therapeutics Lung Drug Keeps Going And Going Dec 19 2014
GSK shareholders approve asset swap deal with Novartis Dec 18 2014
GSK shareholders approve asset swap deal with Novartis Dec 18 2014
GSK shareholders approve asset swap deal with Novartis Dec 18 2014
Novartis sues Cipla over respiratory drug Onbrez Dec 17 2014
Novartis sues Cipla over respiratory drug Onbrez Dec 17 2014
Is This The Future Of Late-Stage Drug Development? Dec 15 2014
Teva Upgraded On Strength Of Copaxone MS Drug Dec 12 2014
Novartis announces results of trial evaluating the use of Afinitor® in first-line treatment in... Dec 12 2014
Head-to-head psoriasis study demonstrates superiority of Novartis Cosentyx(TM) to Stelara® in... Dec 12 2014
The Zacks Analyst Blog Highlights: Novartis, Amgen, Incyte and Allergan Dec 10 2014
Amgen Successfully Expands Xgeva Label in the U.S. Dec 09 2014
Novartis Reports Encouraging Data on Biosimilar of Neupogen Dec 09 2014
Novartis (NVS) Presents Additional Data on Leukemia Drug Dec 08 2014
Novartis announces safety and efficacy benefit of Jakavi® in global clinical trial of over 1,000... Dec 08 2014
Novartis copy of Amgen biotech drug shows similar efficacy-study Dec 08 2014
Novartis highlights new CTL019 clinical data showing complete remissions in children and young... Dec 06 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK